Daily Briefing · 2026-05-21

Pharmacy

Qiagen links with chip giant Nvidia to propel AI use in drug discovery

• Qiagen, a Netherlands-based diagnostics maker, is linking with tech giant Nvidia in a collaboration aimed at boosting the ability of researchers to leverage AI in the drug discovery process.

FierceBiotech ↗

Pharmacy

Incyte pays Genesis $80M to expand AI-fueled drug discovery pact

• Incyte is paying Genesis $80 million upfront to expand use of its partner’s AI platform across a broader range of targets, continuing the biotech’s rapid embrace of AI in drug discovery and development.

FierceBiotech ↗

Pharmacy

BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows

• BMS is the latest large pharma company to make a major bet on AI, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared intelligence platform” across the drugmaker’s global operations

FierceBiotech ↗

Health OS

Labcorp joins lab results personalization push with ‘MyLabcorp’ AI app

• The big new thing in medtech for 2026 is AI-powered apps and chatbots designed to help patients navigate their laboratory test results. Now, testing giant Labcorp is getting in on the act.

FierceBiotech ↗

← All issues